Document 0625
 DOCN  M9620625
 TI    [Peliosis hepatitis during intestinal lymphomatous polyposis treated
       with chemotherapy and radiotherapy. Regression after antibiotic therapy]
 DT    9602
 AU    Abdelli N; Bouhnik Y; Lavergne-Slove A; Messing B; Galian A; Rambaud JC;
       Service d'Hepato-Gastroenterologie et d'Assistance Nutritive,; Hopital
       Saint-Lazare, Paris.
 SO    Gastroenterol Clin Biol. 1995 May;19(5):537-41. Unique Identifier :
       AIDSLINE MED/96008772
 AB    We report a case of regressive peliosis hepatis, which occurred in a 55
       year-old woman with diffuse intestinal lymphomatous polyposis in
       remission after treatment with chemotherapy and radiotherapy, and which
       was cleared after one month treatment with erythromycin. The
       Warthin-Sarry stain, performed to identify a specific agent such as
       Rochalimaea quintana and henselae, was negative, and the polymerase
       chain reaction technique could not be performed. Regressive cases of
       peliosis hepatis are rare, and 4 out of 7 have been reported after
       antibiotic treatment. Two of them were observed after an antibiotic
       regimen with erythromycin in patients with HIV disease, and the bacilli
       Rochalimaea quintana and henselae were identified in liver tissue with
       Warthin-Starry stain and polymerase chain reaction technique. The
       observation and the regressive cases recently reported elsewhere,
       suggest that appropriate antibiotic treatment should be proposed when
       peliosis hepatis occurs.
 DE    Antibiotics, Macrolide/THERAPEUTIC USE  Antineoplastic Agents,
       Combined/THERAPEUTIC USE  Case Report  Combined Modality Therapy
       English Abstract  Erythromycin/*THERAPEUTIC USE  Female  Human
       Intestinal Neoplasms/*COMPLICATIONS/DRUG THERAPY/RADIOTHERAPY  Lymphoma,
       Small Cleaved-Cell, Diffuse/*COMPLICATIONS/DRUG THERAPY/  RADIOTHERAPY
       Middle Age  Peliosis Hepatis/DRUG THERAPY/*ETIOLOGY/PATHOLOGY  Remission
       Induction  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).